Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that the Company will release results for its third quarter of 2026 ended September... Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) ...

Natural flavors are flavoring agents extracted from plant or animal sources — such as spices, fruits, vegetables, dairy, or meat — through heating, roasting, or enzymatic processes. Despite the ...

Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of completion ...

Celiac disease and non-celiac gluten sensitivity (NCGS) require avoiding all gluten-containing foods, including wheat, barley, rye, triticale, spelt, and farro, as well as most breads, pastas, and ...

There are few things I find more exciting than a creative innovation in the beauty industry. Whether it’s buzzy packaging or a fascinating new ingredient, my investigative senses start tingling, and I ...

Paraquat dichloride, commonly referred to as “paraquat,” is one of the most widely used herbicides in the United States. Since paraquat’s first registration, EPA has reviewed and reassessed its safety ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

United Therapeutics Corporation (NASDAQ:UTHR) has received clearance from the U.S. Food and Drug Administration (FDA) to begin clinical testing of Treprostinil-Iloprost SMI, an investigational inhaled ...

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Oct. 19, 2026-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The development of a soft mist inhaler (SMI) represents a further advancement of treprostinil delivery devices to potentially address a wider range of patient tolerability profiles Assuming a ...